• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007

3-Amino-2,2-difluoropropanamide Hydrochloride (CAS No. 2138093-21-5): A Comprehensive Overview

3-Amino-2,2-difluoropropanamide hydrochloride (CAS No. 2138093-21-5) is a versatile compound with significant potential in various fields of chemistry and pharmaceutical research. This compound, characterized by its unique chemical structure and properties, has garnered attention for its potential applications in drug development and medicinal chemistry.

The chemical structure of 3-amino-2,2-difluoropropanamide hydrochloride consists of a propanamide backbone with two fluorine atoms attached to the second carbon atom and an amino group on the third carbon atom. The presence of the hydrochloride salt form enhances its solubility in aqueous solutions, making it suitable for various biochemical assays and pharmaceutical formulations.

Recent studies have highlighted the importance of fluorinated compounds in drug design due to their ability to modulate biological activity and improve pharmacokinetic properties. 3-Amino-2,2-difluoropropanamide hydrochloride is no exception. Its unique structure allows for enhanced lipophilicity and metabolic stability, which are crucial factors in the development of effective drugs.

In the context of medicinal chemistry, 3-amino-2,2-difluoropropanamide hydrochloride has shown promise as a lead compound for the development of novel therapeutics. Research has focused on its potential as an inhibitor of specific enzymes and receptors involved in various disease pathways. For instance, studies have demonstrated its ability to inhibit certain kinases, which are key targets in cancer therapy.

The pharmacological profile of 3-amino-2,2-difluoropropanamide hydrochloride has been extensively studied using both in vitro and in vivo models. In vitro assays have shown that this compound exhibits potent inhibitory activity against specific targets, with low micromolar IC50 values. These findings suggest that it could be a valuable candidate for further optimization and development into a therapeutic agent.

Clinical trials are an essential step in the drug development process, and preliminary studies have indicated that 3-amino-2,2-difluoropropanamide hydrochloride has favorable safety and tolerability profiles. Preclinical data have demonstrated that it is well-tolerated at therapeutic doses and does not exhibit significant toxicity or adverse effects.

Beyond its potential as a therapeutic agent, 3-amino-2,2-difluoropropanamide hydrochloride also holds promise as a research tool. Its unique properties make it useful for studying the effects of fluorination on biological activity and for exploring new chemical space in drug discovery. Researchers can use this compound to gain insights into the structure-activity relationships (SAR) of fluorinated molecules and to identify novel scaffolds with improved pharmacological properties.

In conclusion, 3-amino-2,2-difluoropropanamide hydrochloride (CAS No. 2138093-21-5) is a promising compound with a wide range of potential applications in both research and pharmaceutical development. Its unique chemical structure and favorable biological properties make it an attractive candidate for further investigation and optimization. As research in this area continues to advance, it is likely that new opportunities will emerge for the use of this compound in the treatment of various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)